ArticlePloS one2025
Role of COVID-19 infection status on the prediction of future infection: Immunity or susceptibility.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCOVID-19 has rapidly spread around the world, and the duration of protective immunity against the virus remains unknown. Evidence suggests that patients with a confirmed COVID-19 infection may experience reinfection. The aim of this study is to determine the relationship between COVID-19 reinfection and previous infection history in the population covered by Mashhad University of Medical Sciences.
methodsThis population-based, historical cohort study included all individuals with health records at the health service centers of Mashhad University of Medical Sciences who underwent PCR testing during the study period (April 1, 2020, up to February 19, 2022). The data were analyzed by calculating the infection rate in both PCR-positive and negative individuals, and estimating the adjusted rate ratio using Poisson regression.
resultsThe results of this study in the entire population showed that the incidence rate in people with a history of primary COVID-19 infection was 13% higher than that in people who had no history of this disease. However, in the group that received the vaccine prior to the first PCR test, the incidence rate was lower among individuals with a positive first test result (IRR = 0.71) compared to those with a negative first test result.
conclusionThe study reveals that prior COVID-19 infection does not ensure immunity and may increase the risk of reinfection, particularly among men and younger individuals. Vaccination appears to complicate this dynamic, as those with multiple vaccine doses showed higher reinfection rates compared to those with fewer doses. These findings highlight the need for ongoing research and tailored public health strategies to address the complexities of COVID-19 immunity and reinfection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.